INS and Hypoglycemia: In the NICE–SUGAR trial, patients who underwent intensive insulin therapy for tight glucose control had more frequent severe hypoglycaemias than patients in the control arm (6.8% vs 0.5%) and a significantly increased mortality (OR 1.14 [95% CI 1.02–1.28]) [5].